D MAX developed the branding for this $150 million Federal Government / Private enterprise partnership to develop small molecular drugs to treat cancer.

In addition to designing the logo and corporate identity, D MAX also developed all the corporate communications including a promotional video, the design of the website and several publications including a highlights document (download the PDF here - 2.27MB).